PTCT
PTC Therapeutics Inc
Price:  
35.62 
USD
Volume:  
800,126.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PTCT EV/EBITDA

-84.5%
Upside

As of 2024-06-20, the EV/EBITDA ratio of PTC Therapeutics Inc (PTCT) is 43.87. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PTCT's latest enterprise value is 4,324.66 mil USD. PTCT's TTM EBITDA according to its financial statements is 98.57 mil USD. Dividing these 2 quantities gives us the above PTCT EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 17.5x - 21.5x 18.6x
Forward P/E multiples 20.3x - 23.3x 22.4x
Fair Price 1.68 - 9.16 5.52
Upside -95.3% - -74.3% -84.5%
35.62 USD
Stock Price
5.52 USD
Fair Price

PTCT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-18 43.87
2024-06-17 43.70
2024-06-14 44.02
2024-06-13 44.87
2024-06-12 45.47
2024-06-11 45.48
2024-06-10 45.42
2024-06-07 44.57
2024-06-06 44.89
2024-06-05 45.72
2024-06-04 45.65
2024-06-03 45.28
2024-05-31 44.45
2024-05-30 44.02
2024-05-29 43.41
2024-05-28 44.53
2024-05-24 45.10
2024-05-23 45.05
2024-05-22 46.22
2024-05-21 46.39
2024-05-20 47.37
2024-05-17 41.91
2024-05-16 42.63
2024-05-15 42.35
2024-05-14 40.42
2024-05-13 40.82
2024-05-10 41.25
2024-05-09 40.32
2024-05-08 40.39
2024-05-07 40.89
2024-05-06 41.80
2024-05-03 41.84
2024-05-02 42.32
2024-05-01 42.74
2024-04-30 41.17
2024-04-29 41.16
2024-04-26 38.39
2024-04-25 35.99
2024-04-24 35.77
2024-04-23 35.93
2024-04-22 36.36
2024-04-19 35.86
2024-04-18 35.37
2024-04-17 35.73
2024-04-16 35.83
2024-04-15 36.14
2024-04-12 36.71
2024-04-11 37.48
2024-04-10 37.09
2024-04-09 37.63